# Jacob A. Torres

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jacob-a-torres/

## Facts

| Field | Value |
| --- | --- |
| Citations | 610 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | University of California, Santa Barbara |
| OpenAlex ID | https://openalex.org/A5078532805 |
| ORCID iD | 0000-0003-4005-8314 |
| Works | 35 |

## Researcher papers

- [Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease](https://scholariq.org/papers/ketosis-ameliorates-renal-cyst-growth-in-polycystic-kidney-disease/)
- [Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease](https://scholariq.org/papers/crystal-deposition-triggers-tubule-dilation-that-accelerates-cystogenesis-in/)
- [Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial](https://scholariq.org/papers/feasibility-and-impact-of-ketogenic-dietary-interventions-in-polycystic-kidney/)
- [Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects](https://scholariq.org/papers/ketogenic-dietary-interventions-in-autosomal-dominant-polycystic-kidney-disease/)
- [Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease](https://scholariq.org/papers/emerging-targeted-strategies-for-the-treatment-of-autosomal-dominant-polycystic/)
- [STAT signaling in polycystic kidney disease](https://scholariq.org/papers/stat-signaling-in-polycystic-kidney-disease/)
- [Ren.Nu, a Dietary Program for Individuals with Autosomal-Dominant Polycystic Kidney Disease Implementing a Sustainable, Plant-Focused, Kidney-Safe, Ketogenic Approach with Avoidance of Renal Stressors](https://scholariq.org/papers/ren-nu-a-dietary-program-for-individuals-with-autosomal-dominant-polycystic/)
- [Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease](https://scholariq.org/papers/identification-of-targets-of-il-13-and-stat6-signaling-in-polycystic-kidney/)
- [A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease](https://scholariq.org/papers/a-combination-of-hydroxybutyrate-and-citrate-ameliorates-disease-progression-in/)
- [β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease](https://scholariq.org/papers/hydroxybutyrate-recapitulates-the-beneficial-effects-of-ketogenic-metabolic/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Biomedical Research and Pathophysiology](https://scholariq.org/topics/biomedical-research-and-pathophysiology/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [University of California, Santa Barbara](https://scholariq.org/institutions/university-of-california-santa-barbara/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.